U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 218197

Expand all

TRUQAP (CAPIVASERTIB)
160MG
Marketing Status: Prescription
Active Ingredient: CAPIVASERTIB
Proprietary Name: TRUQAP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 160MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N218197
Product Number: 001
Approval Date: Nov 16, 2023
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information
TRUQAP (CAPIVASERTIB)
200MG
Marketing Status: Prescription
Active Ingredient: CAPIVASERTIB
Proprietary Name: TRUQAP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N218197
Product Number: 002
Approval Date: Nov 16, 2023
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top